The HPV-16 E7 oncoprotein induces centriole multiplication through deregulation of Polo-like kinase 4 expression

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Korzeniewski, Nina ^a   Treat, Benjamin ^b   Duensing, Stefan ^a,b,c  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; POLO LIKE KINASE 4; PROTEIN E7; PROTEIN KINASE; UNCLASSIFIED DRUG; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; PLK4 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

ARTICLE; BIOENGINEERING; CELL DIVISION; CENTRIOLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROMOTER REGION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

CENTRIOLES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PAPILLOMAVIRUS E7 PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; UP-REGULATION;

EID: 79956266394     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-61     Document Type: Article

References (29)

1. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2:342-350. 10.1038/nrc798, 12044010.
2. Korzeniewski N, Spardy N, Duensing A, Duensing S. Genomic instability and cancer: Lessons learned from human papillomaviruses. Cancer Lett 2011, 305:113-122. 10.1016/j.canlet.2010.10.013, 21075512.
3. McLaughlin-Drubin ME, Munger K. The human papillomavirus E7 oncoprotein. Virology 2009, 384:335-344. 10.1016/j.virol.2008.10.006, 2661820, 19007963.
4. Longworth MS, Laimins LA. The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31. J Virol 2004, 78:3533-3541. 10.1128/JVI.78.7.3533-3541.2004, 371089, 15016876.
5. Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T. The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J 1999, 18:2449-2458. 10.1093/emboj/18.9.2449, 1171327, 10228159.
6. Hwang SG, Lee D, Kim J, Seo T, Choe J. Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner. J Biol Chem 2002, 277:2923-2930. 10.1074/jbc.M109113200, 11713253.
7. McLaughlin-Drubin ME, Huh KW, Munger K. Human papillomavirus type 16 E7 oncoprotein associates with E2F6. J Virol 2008, 82:8695-8705. 10.1128/JVI.00579-08, 2519642, 18579589.
8. Nguyen CL, Munger K. Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes. Virology 2008, 380:21-25. 10.1016/j.virol.2008.07.017, 2574417, 18718623.
9. He W, Staples D, Smith C, Fisher C. Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7. J Virol 2003, 77:10566-10574. 10.1128/JVI.77.19.10566-10574.2003, 228519, 12970441.
10. Duensing S, Munger K. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer 2004, 109:157-162. 10.1002/ijc.11691, 14750163.
11. Nigg EA. Centrosome duplication: of rules and licenses. Trends Cell Biol 2007, 17:215-221. 10.1016/j.tcb.2007.03.003, 17383880.
12. Azimzadeh J, Bornens M. Structure and duplication of the centrosome. J Cell Sci 2007, 120:2139-2142. 10.1242/jcs.005231, 17591686.
13. Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature 2009, 460:278-282. 10.1038/nature08136, 2743290, 19506557.
14. Duensing A, Spardy N, Chatterjee P, Zheng L, Parry J, Cuevas R, Korzeniewski N, Duensing S. Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins. Environ Mol Mutagen 2009, 50:741-747. 10.1002/em.20478, 19326465.
15. Tsou MF, Wang WJ, George KA, Uryu K, Stearns T, Jallepalli PV. Polo kinase and separase regulate the mitotic licensing of centriole duplication in human cells. Dev Cell 2009, 17:344-354. 10.1016/j.devcel.2009.07.015, 2746921, 19758559.
16. Kleylein-Sohn J, Westendorf J, Le Clech M, Habedanck R, Stierhof YD, Nigg EA. Plk4-induced centriole biogenesis in human cells. Dev Cell 2007, 13:190-202. 10.1016/j.devcel.2007.07.002, 17681131.
17. Duensing S, Duensing A, Crum CP, Munger K. Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype. Cancer Res 2001, 61:2356-2360.
18. Duensing A, Liu Y, Perdreau SA, Kleylein-Sohn J, Nigg EA, Duensing S. Centriole overduplication through the concurrent formation of multiple daughter centrioles at single maternal templates. Oncogene 2007, 26:6280-6288. 10.1038/sj.onc.1210456, 2586811, 17438528.
19. Duensing A, Chin A, Wang L, Kuan SF, Duensing S. Analysis of centrosome overduplication in correlation to cell division errors in high-risk human papillomavirus (HPV)-associated anal neoplasms. Virology 2008, 372:157-164. 10.1016/j.virol.2007.10.030, 2267749, 18036631.
20. Korzeniewski N, Zheng L, Cuevas R, Parry J, Chatterjee P, Anderton B, Duensing A, Munger K, Duensing S. Cullin 1 functions as a centrosomal suppressor of centriole multiplication by regulating polo-like kinase 4 protein levels. Cancer Res 2009, 69:6668-6675. 10.1158/0008-5472.CAN-09-1284, 2727667, 19679553.
21. Piel M, Meyer P, Khodjakov A, Rieder CL, Bornens M. The respective contributions of the mother and daughter centrioles to centrosome activity and behavior in vertebrate cells. J Cell Biol 2000, 149:317-330. 10.1083/jcb.149.2.317, 2175166, 10769025.
22. Habedanck R, Stierhof YD, Wilkinson CJ, Nigg EA. The Polo kinase Plk4 functions in centriole duplication. Nat Cell Biol 2005, 7:1140-1146.
23. Cunha-Ferreira I, Rodrigues-Martins A, Bento I, Riparbelli M, Zhang W, Laue E, Callaini G, Glover DM, Bettencourt-Dias M. The SCF/Slimb ubiquitin ligase limits centrosome amplification through degradation of SAK/PLK4. Curr Biol 2009, 19:43-49. 10.1016/j.cub.2008.11.037, 19084407.
24. Fode C, Binkert C, Dennis JW. Constitutive expression of murine Sak-a suppresses cell growth and induces multinucleation. Mol Cell Biol 1996, 16:4665-4672. 231466, 8756623.
25. Rogers GC, Rusan NM, Roberts DM, Peifer M, Rogers SL. The SCF Slimb ubiquitin ligase regulates Plk4/Sak levels to block centriole reduplication. J Cell Biol 2009, 184:225-239. 10.1083/jcb.200808049, 2654306, 19171756.
26. Karlseder J, Rotheneder H, Wintersberger E. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol Cell Biol 1996, 16:1659-1667. 231152, 8657141.
27. Li J, Tan M, Li L, Pamarthy D, Lawrence TS, Sun Y. SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing. Neoplasia 2005, 7:312-323. 10.1593/neo.04325, 1501148, 15967108.
28. Duensing S, Munger K. Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members. J Virol 2003, 77:12331-12335. 10.1128/JVI.77.22.12331-12335.2003, 254291, 14581569.
29. Duensing A, Liu Y, Spardy N, Bartoli K, Tseng M, Kwon JA, Teng X, Duensing S. RNA polymerase II transcription is required for human papillomavirus type 16 E7- and hydroxyurea-induced centriole overduplication. Oncogene 2007, 26:215-223. 10.1038/sj.onc.1209782, 2228273, 16819507.